Skip to main content

Tweets

2023 EULAR Lupus Management Recommendations EULAR has published updated recommendations for the management of systemic lupus erythematosus (SLE) based on new evidence and expert opinion - formulationg five overarching principles and 13 recommendations. https://t.co/LainTFQBDg https://t.co/4b4h1fy6M3
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
JAKne? Systematic review &meta-analysis (25 studies, 10 839 pts), JAK inhibitor use was associated with an elevated odds of acne (OR 3-5 for UPA, TOFA, BARI, Deucra; but higher for abrocitinib (OR 13.5). Seen in Derm pts but hardly at all in Rheum pts https://t.co/En8HCqwqjO https://t.co/ak216wmlBA
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Genetic links for Raynauds Phen (RP): Large GWAS study of 5147 RP cases in the UK Biobank cohort shows 2 robust and strong (p < 4.8 × 10−13) novel loci A) ADRA2A (rs7090046, OR per allele: 1.26) & B) IRX1 (rs12653958, OR: 1.17) as candidate causal genes https://t.co/W6F736uskO https://t.co/u1IZnIy7wg
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Hong Kong study of 12233 RA pts followed 8.7 yrs, and 7% developed MACE. Daily Pred ≥5 mg signif increased the MACE risk (HR ~ 2), dose-dependent fashion; YET Pred <5 mg/d was not associated with MACE risk (vs No GC) https://t.co/26peaYp4kQ https://t.co/ooax9iTZYo
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
12.3 million Americans over 50 have osteoporosis; 47 million have osteopenia. W/ OP Fx the risk of repeat Fx is highest in 1st 6 mos, yet 8% of Medicare pts w/ Fx have a diagnostic bone density scan (less in African Americans 5%) https://t.co/xBHr7WffYf https://t.co/S27Vs8yyjY https://t.co/eWcOB8fjWH
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Sleep problems in SpA & PsA? Study of 201 pts shows 43% of axSpA and 47% of PsA pts reported sleep problems. In both poor sleep assoc w/ dz activity. In axSpa it signif assoc w/ Dz activity (OR 8.45),biologic use (OR .24), & CRP levels (OR .16) https://t.co/7juI2Dghjh https://t.co/SxCaJgTmeQ
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Bimekizumab (Bimelex), a dual IL-17A/F inhibitor, is FDA approved for u Treatment of Adults with Moderate to Severe Plaque Psoriasis https://t.co/Eo4LMaTHxn https://t.co/abzlThasEN
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
#PMR with Cancer Dr. Sebastian Sattui (Pittsburgh, PA) Can PMR be a paraneoplastic presentation? https://t.co/GsQ5FoDGPK https://t.co/ybHMmi72TG
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Innovative, full-read, state-of-the-art article on IMAGING in INFLAMMATORY ARTHRITIS & its future role in precision medicine. "Imaging is poised to become an invaluable tool in precision medicine..". HR-pQCT, 3T or 7T MRI, FAPI PET–CT, CEUS, FOI, etc https://t.co/fGQVEOkea9 https://t.co/XyvtZj85Hk
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Check out my other podcast - the Miracle Larry Podcast. Miracle Larry gave the keynote lecture at RNL2023. A podcast focused on his amazing story. Follow us @Miracle_LarryK. We’d appreciate the support! https://t.co/6zi2D7hdGJ

Dr. John Cush @RheumNow ( View Tweet )

2 years 4 months ago
What Goes Wrong with the Immune System in #PMR? https://t.co/3DDFXBOfaL https://t.co/WNiWpokP4q
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
Using Methotrexate in #PMR Where in other inflammatory rheumatic disorders, such as RA and PsA, early initiation of MTX is common practice, this is not the case in PMR. Treatment of PMR is still largely based on GC. https://t.co/pQtmYvF2NS https://t.co/wJTpFPqmlw
Dr. John Cush @RheumNow ( View Tweet )
2 years 4 months ago
×